Latest News

November 14, 2021

World Diabetes Day 2021

November 14 is World Diabetes Day and the theme for 2021 is "Diabetes Cares: If Not Now Then When?" One aspect of diabetes care is access to a healthy diet and physical activity. The groundbreaking research of our diabetes team at the NeuroNetwork of Emerging Therapies is proving more and more why this is so important.

November 11, 2021

DMM: 3 Publications Included in 100 Years of Insulin Celebration

It has been 100 years since the discovery of insulin. To celebrate this centenary, Disease Models & Mechanisms explores ongoing research in diabetes, including three publications from Drs. Eva Feldman, Stephanie Eid, Sarah Elzinga, and former lab member Dr. Phillip O'Brien.

November 1, 2021

U.S. News & World Report features Dr. Brian Callaghan

On small fiber neuropathy: "Doctors, and especially neurologists, are more aware of this condition than they were 10 years ago," said Dr. Brian Callaghan, an associate professor of neurology at the University of Michigan Medical School in Ann Arbor. Callaghan co-wrote an editorial accompanying the new study.

October 23, 2021

Dr. Stephen Goutman featured on WWJ Newsradio 950

Deanna Lites speaks to Dr. Goutman about why it's important to look at environmental factors in ALS, which will be part of the new ALS medical moonshot thanks to a $3.6 million grant from the NIH.

logo for One Detroit on Detroit Public Television
October 18, 2021

PBS/Detroit Public Television Features Dr. Eva Feldman on Long COVID

"We’ve had multi-millions of cases of COVID in this country. I mean let’s do the math, when 20 percent of those individuals – we’re talking about millions of individuals who have long COVID, those individuals are really impaired." Dr. Eva Feldman speaks to One Detroit's Bill Kubota on Detroit Public Television about Long COVID.

NIH Director's Transformative Research Award logo
October 5, 2021

Announcing NIH Director's Transformative Research Award

A multidisciplinary group of University of Michigan researchers will investigate environmental exposures, chosen as one of the first projects in a new National Institutes of Health amyotrophic lateral sclerosis initiative.

October 1, 2021

New CDC Grant to Study Air Pollution & ALS

A CDC-funded multidisciplinary effort at U-M will investigate air pollution as a major and modifiable risk factor for ALS and seek to identify therapy targets.

September 20, 2021

Therapeutic Approvals: The US vs The UK

In a recent publication, Dr. Brian Callaghan looks at how the approach of approving drug therapies differs between the United State and the United Kingdom.

photo of Dr. Stephen Goutman
September 1, 2021

National ALS Registry Meeting 2021: Featuring Dr. Stephen Goutman

The National ALS Registry, managed by the Center for Disease Control (CDC) is one of the most important weapons in the fight against Amyotrophic Lateral Sclerosis (ALS). At the Annual Surveillance Meeting, Pranger ALS Clinic Director Dr. Stephen Goutman presented an update of important findings funded by the CDC.

July 22, 2021

World Brain Day 2021

In honor of World Brain Day, established by the World Federation of Neurology, we wanted to share a selection of brain imaging from our research.

July 13, 2021

Dr. Feldman featured on IASP Pain Research Forum Podcast

Speaking to the joint Harvard NeuroDiscovery Center and MassGeneral Institute for Neurodegenerative Disease Informatics group, Dr. Feldman discusses the problem of diabetic neuropathy, its causes and treatment, and our lab investigations of this condition.

June 28, 2021

ADA 2021: A Debate on Neuropathy Testing

Dr. Brian Callaghan shares his position about the current problems of diabetic neuropathy testing. He presented this argument during a debate at the American Diabetes Association's 81st Scientific Sessions.

Pages